Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (“Zimmer Biomet”), a global medical technology leader, announces it has completed the acquisition of Monogram Technologies Inc. (“Monogram”), an AI-driven, next-generation orthopedic robotics company. Monogram’s surgeon-guided semi- and fully autonomous robotic technologies are expected to add new and differentiated capabilities to Zimmer Biomet’s already broad suite of customer-centric technology solutions. Monogram has developed a CT-based, semi-autonomous, AI-navigated total knee arthroplasty (TKA) robotic technology, which received FDA 510(k) clearance in March 2025.
Read the full article: Zimmer Biomet Completes Acquisition of Monogram Technologies //
Source: https://www.prnewswire.com/news-releases/zimmer-biomet-completes-acquisition-of-monogram-technologies-302577035.html